Skip to main content

. 1985 Jan 26;290(6464):284–285. doi: 10.1136/bmj.290.6464.284-a

Long term treatment of acromegaly with a long acting analogue of somatostatin.

L J Ch'ng, L M Sandler, M E Kraenzlin, J M Burrin, G F Joplin, S R Bloom

PMCID: PMC1417552 PMID: 2857104

284

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bauer W., Briner U., Doepfner W., Haller R., Huguenin R., Marbach P., Petcher T. J., Pless SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982 Sep 13;31(11):1133–1140. doi: 10.1016/0024-3205(82)90087-x. [DOI] [PubMed] [Google Scholar]
Besser G. M., Mortimer C. H., Carr D., Schally A. V., Coy D. H., Evered D., Kastin A. J., Tunbridge W. M., Thorner M. O., Hall R. Growth hormone release inhibiting hormone in acromegaly. Br Med J. 1974 Mar 2;1(5904):352–355. doi: 10.1136/bmj.1.5904.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
Daughaday W. H., Cryer P. E. Growth hormone hypersecretion and acromegaly. Hosp Pract. 1978 Aug;13(8):75–80. doi: 10.1080/21548331.1978.11707385. [DOI] [PubMed] [Google Scholar]
Lamberg B. A., Kivikangas V., Vartianen J., Raitta C., Pelkonen R. Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion. Acta Endocrinol (Copenh) 1976 Jun;82(2):267–281. [PubMed] [Google Scholar]
McGuffin W. L., Jr, Sherman B. M., Roth F., Gorden P., Kahn C. R., Roberts W. C., Frommer P. L. Acromegaly and cardiovascular disorders. A prospective study. Ann Intern Med. 1974 Jul;81(1):11–18. doi: 10.7326/0003-4819-81-1-11. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES